日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Induction Chemotherapy Followed by Immunotherapy Increases Pathological Complete Response Rate in dMMR/MSI-H Gastric Cancer: A Retrospective Cohort Study

诱导化疗联合免疫治疗可提高dMMR/MSI-H胃癌的病理完全缓解率：一项回顾性队列研究

期刊:ImmunoTargets and Therapy
影响因子:4.4
doi:10.2147/ITT.S564230
Zeng, Hong; Wu, Yingying; Zhang, Ziwei; Liu, Jingdong; Sun, Jie; Liu, Xinyou; Gu, Yuan; Tian, Mengxin; Chen, Weidong; Shen, Zhenbin; Shen, Kuntang; Xu, Chen; Wang, Xuefei; Tang, Zhaoqing; Sun, Yihong
胃癌
肿瘤
肿瘤免疫
多发性骨髓瘤
多发性硬化症
免疫/内分泌
发表日期：2026
文献求助 收藏

Long Non-Coding RNA CTD-2245E15.3 Drives Proliferation and Migration in Gastrointestinal Stromal Tumors

长链非编码RNA CTD-2245E15.3驱动胃肠道间质瘤的增殖和迁移

期刊:Biomedicines
影响因子:3.9
doi:10.3390/biomedicines14030514
Sun, Xiangfei; Sun, Yinwen; Shu, Ping; Yi, Tuo; Shen, Kuntang; Niu, Weixin; Hong, Xinqiang
发表日期：2026
文献求助 收藏

Tumor mutation burden predicts aggressiveness and prognosis of gastrointestinal stromal tumor

肿瘤突变负荷可预测胃肠道间质瘤的侵袭性和预后

期刊:Translational Cancer Research
影响因子:1.7
doi:10.21037/tcr-2025-1-2552
Sun, Jianyi; Xue, Anwei; Lu, Jiangshen; Shen, Kuntang; Wang, Hongshan; Gao, Xiaodong
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Hidden risk factors for recurrence of jejunoileal Gastrointestinal stromal tumors with low NIH classification: implications for surveillance and adjuvant therapy

低NIH分级空回肠胃肠道间质瘤复发的隐匿风险因素：对监测和辅助治疗的启示

期刊:Journal of Translational Medicine
影响因子:7.5
doi:10.1186/s12967-025-07163-1
Sun, Xiangfei; Sun, Yinwen; Xiong, Ran; Zhou, Yuning; Gao, Xiaodong; Hou, Yingyong; Shen, Kuntang; Shu, Ping
发表日期：2025
文献求助 收藏

Circulating tumor DNA analysis for prediction of prognosis and molecular insights in patients with resectable gastric cancer: results from a prospective study

循环肿瘤 DNA 分析对可切除胃癌患者预后和分子见解的预测：一项前瞻性研究的结果

期刊:MedComm
影响因子:
doi:10.1002/mco2.70065
Zheng Liu, Zhongyi Shi, Wenchao Jiang, Zhenbin Shen, Weidong Chen, Kuntang Shen, Yihong Sun, Zhaoqing Tang, Xuefei Wang
肿瘤
胃癌
发表日期：2025
文献求助 收藏

Proteomic Characterization Identifies Clinically Relevant Subgroups of Gastrointestinal Stromal Tumors

蛋白质组学表征鉴定胃肠道间质瘤的临床相关亚群

期刊:Gastroenterology
影响因子:25.7
doi:10.1053/j.gastro.2023.11.284
Mingjun Sun, Yexin Tong, Wei Yuan, Yunzhi Wang, Yan Pu, Wen Huang, Boqiong Lv, Chen Xu, Wei Jiang, Rongkui Luo, Rundong Fang, Shaoshuai Tang, Lei Ren, Jiachen Wang, Jinwen Feng, Cheng Sun, Kuntang Shen, Fuchu He, Yingyong Hou, Chen Ding
肿瘤
胃癌
发表日期：2024
文献求助 收藏

Safety, effectiveness and the optimal duration of preoperative imatinib in locally advanced gastric gastrointestinal stromal tumors: A retrospective cohort study

局部晚期胃肠道间质瘤术前伊马替尼治疗的安全性、有效性及最佳疗程：一项回顾性队列研究

期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.70237
Sun, Xiangfei; Lin, Xiaohan; Zhang, Qiang; Li, Chao; Shu, Ping; Gao, Xiaodong; Shen, Kuntang
发表日期：2024
文献求助 收藏

Imatinib induces ferroptosis in gastrointestinal stromal tumors by promoting STUB1-mediated GPX4 ubiquitination

伊马替尼通过促进 STUB1 介导的 GPX4 泛素化诱导胃肠道间质瘤铁死亡

期刊:Cell Death & Disease
影响因子:8.1
doi:10.1038/s41419-023-06300-2
Xiangfei Sun #, Qiang Zhang #, Xiaohan Lin #, Ping Shu, Xiaodong Gao, Kuntang Shen
信号转导
细胞生物学
肠癌
发表日期：2023
文献求助 收藏

Efficacy and Safety of Avapritinib in Treating Unresectable or Metastatic Gastrointestinal Stromal Tumors: A Phase I/II, Open-Label, Multicenter Study

阿伐替尼治疗不可切除或转移性胃肠道间质瘤的疗效和安全性：一项 I/II 期、开放标签、多中心研究

期刊:Oncologist
影响因子:4.2
doi:10.1093/oncolo/oyac242
Li, Jian; Zhang, Xinhua; Deng, Yanhong; Wu, Xin; Zheng, Zhichao; Zhou, Yongjian; Cai, Shirong; Zhang, Yanqiao; Zhang, Jun; Tao, Kaixiong; Cui, Yuehong; Cao, Hui; Shen, Kuntang; Yu, Jiren; Zhou, Ye; Ren, Wenxiao; Qu, Chenglin; Zhao, Wanqi; Hu, Jin; Wang, Wei; Yang, Jason; Shen, Lin
发表日期：2023
文献求助 收藏

COLEC12 Promotes Tumor Progression and Is Correlated With Poor Prognosis in Gastric Cancer

COLEC12 促进肿瘤进展并与胃癌预后不良相关

期刊:Technology in Cancer Research & Treatment
影响因子:2.7
doi:10.1177/15330338231218163
Xiangfei Sun, Qiang Zhang, Ping Shu, Xiaohan Lin, Xiaodong Gao, Kuntang Shen
肿瘤
胃癌
发表日期：2023
文献求助 收藏